Dear colleagues,
A reaction by the EN13606 Association in response to:
> a request by the FDA on questions such as "- What are the advantages and
> disadvantages of HL7 v3 and CDISC ODM?"
> And, interestingly, they also ask: "- Are there other open data exchange
> standards that should be eva
FDA seeks "input from industry, technology vendors, and other members of the
public regarding the advantages and disadvantages of current and emerging open,
consensus-based standards for the exchange of regulated study data. "
In the annoncement for a meeting 5 November FDA ask for responses, b
